RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Khosrow Kashfi to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Khosrow Kashfi has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Khosrow Kashfi
Connection Strength
0.883
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Patel KK, Sehgal VS, Kashfi K. Molecular targets of statins and their potential side effects: Not all the glitter is gold. Eur J Pharmacol. 2022 May 05; 922:174906.
    View in: PubMed
    Score: 0.692
  2. Patel KK, Kashfi K. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem Pharmacol. 2022 02; 196:114654.
    View in: PubMed
    Score: 0.164
  3. Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015 Dec; 6:334-343.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support